Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study

Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study

Purpose: To analyze the efficacy and safety of standard-dose antimuscarinic treatment on male patients with overactive bladder (OAB) symptoms showing poor efficacy after low-dose antimuscarinics. Materials and Methods: We retrospectively reviewed the data of 566 male patients aged ≥40 with OAB sympt...

Full description

Bibliographic Details
Main Authors:	Myungsun Shim, Jong Keun Kim, Woo Jin Bang, Yong Seong Lee, Sung Tae Cho, Jin Seon Cho, Kwan Joong Joo, Jae Seog Hyun, Byung Hoon Kim, Jong Bok Lee, Young Jin Seo, Cheol Young Oh
Format:	Article
Language:	English
Published:	Korean Urological Association 2020-11-01
Series:	Investigative and Clinical Urology
Subjects:	muscarinic antagonists prostatic hyperplasia treatment outcome urinary bladder overactive
Online Access:	https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-600.pdf

Similar Items

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors
by: Kirill Vladimirovich Kosilov, et al.
Published: (2017-03-01)

Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
by: Hee Seo Son, et al.
Published: (2022-06-01)

Maintenance of the Therapeutic Effect of Two High-Dosage Antimuscarinics in the Management of Overactive Bladder in Elderly Women
by: Kirill Kosilov, et al.
Published: (2013-12-01)

The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction
by: Jin Bong Choi, et al.
Published: (2020-04-01)

Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of Drug-Receptor Binding
by: Shizuo Yamada, et al.
Published: (2012-09-01)

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin
by: Marloes J. Tijnagel, et al.
Published: (2017-04-01)

Persistence and compliance with medication management in the treatment of overactive bladder
by: Tae Heon Kim, et al.
Published: (2016-03-01)

Current pharmacotherapy of overactive bladder
by: Evgenyi I. Kreydin, et al.
Published: (2021-10-01)

Literature Review: Efektivitas, Keamanan, dan Biaya Terapi Imidafenacin untuk Pasien Overactive Bladder
by: Steven Victoria Halim
Published: (2020-12-01)

Long-Term Efficacy of Mirabegron Add-On Therapy to Antimuscarinic Agents in Patients With Spinal Cord Injury
by: Seok-Hee Han, et al.
Published: (2019-02-01)

Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors
by: Sheng-Mou Hsiao, et al.
Published: (2015-09-01)

The challenge of overactive bladder therapy: alternative to antimuscarinic agents
by: Massimo Lazzeri, et al.
Published: (2006-12-01)

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
by: Hoon Choi, et al.
Published: (2018-03-01)

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
by: Hyun Seok Na, et al.
Published: (2024-03-01)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
by: Jameel Nazir, et al.
Published: (2018-09-01)

Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
by: Löfling L, et al.
Published: (2019-01-01)

Effect of Antimuscarinic Drugs on Cognitive Functions in the Management of Overactive Bladder in Elderly
by: Ervandy Rangganata, et al.
Published: (2020-10-01)

Overactive bladder – 18 years – Part II
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study
by: Vinit Kumar Srivastava, et al.
Published: (2020-04-01)

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study
by: Se Yun Kwon, et al.
Published: (2020-07-01)

Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients
by: Yuh-Chen Kuo, et al.
Published: (2023-01-01)

The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
by: Tomonori Yamanishi, et al.
Published: (2015-06-01)

MODERN POSSIBILITIES OF MEDICAL TREATMENT OF OVERACTIVE BLADDER IN WOMEN
by: I. A. Apolikhina, et al.
Published: (2017-12-01)

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice
by: Kwang Jin Ko, et al.
Published: (2023-05-01)

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK
by: Zalmai Hakimi, et al.
Published: (2018-01-01)

Comparison of efficacy and side-effects of Oxybutynin and Tolterodine in the treatment of overactive bladder
by: Ghanbari Z, et al.
Published: (2011-08-01)

Time Course of Treatment for Primary Enuresis With Overactive Bladder
by: Young Jae Im, et al.
Published: (2018-06-01)

A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity
by: Luke D. J. Thomson, et al.
Published: (2022-08-01)

The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder
by: Ji Hyun Kim, et al.
Published: (2011-12-01)

A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
by: Jung Hyun Shin, et al.
Published: (2023-06-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

Low dose intradetrusor injections of onabotulinumtoxinA in women with overactive bladder symptoms or the painful bladder syndrome: unfavorable balance between clinical efficacy and the need for catheterization
by: Jan Groen, et al.
Published: (2012-10-01)

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
by: Yoon Seok Suh, et al.
Published: (2017-09-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Protective Effects of Antimuscarinics on the Bladder Remodeling After Bladder Outlet Obstruction
by: Qiang Liu, et al.
Published: (2017-11-01)

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment
by: Aram Kim, et al.
Published: (2017-01-01)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
by: Danny Ulahannan, et al.
Published: (2009-04-01)

Low dose intradetrusor injections of onabotulinumtoxina in women with overactive bladder symptoms or the painful bladder syndrome: unfavourable balance between clinical efficacy and the need for catheterisation
by: Jan Groen, et al.
Published: (2012-01-01)

The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms
by: Paulina Iwaniak, et al.
Published: (2023-10-01)